Suppr超能文献

血栓性血小板减少性紫癜患者的血浆细胞因子水平

Plasma cytokine levels in thrombotic thrombocytopenic purpura.

作者信息

Wada H, Kaneko T, Ohiwa M, Tanigawa M, Tamaki S, Minami N, Takahashi H, Deguchi K, Nakano T, Shirakawa S

机构信息

Second Department of Internal Medicine, Mie University School of Medicine, Mie Ken, Japan.

出版信息

Am J Hematol. 1992 Jul;40(3):167-70. doi: 10.1002/ajh.2830400303.

Abstract

Plasma cytokine levels were examined in 13 patients with thrombotic thrombocytopenic purpura (TTP). Auto-antibodies, platelet-associated immunoglobulin G, and platelet aggregating factor were detected in many of these patients and high-molecular-weight bands of von Willebrand factor multimers were reduced in 9 of 10 patients examined. Complete remission (CR) was attained in 7 of the 13 patients, but 6 died. Tumor necrosis factor (TNF), Interleukin (IL)-1 beta, IL-6, and soluble IL-2 receptor showed marked increases at onset and decreased at CR. The prognosis tended to be poor in patients with increased IL-6 and soluble IL-2 receptor levels. These findings suggest that immunological mechanisms, such as the activation of macrophage, are involved in the pathogenesis of TTP and are reflected in the plasma cytokine levels.

摘要

对13例血栓性血小板减少性紫癜(TTP)患者的血浆细胞因子水平进行了检测。在许多这类患者中检测到自身抗体、血小板相关免疫球蛋白G和血小板聚集因子,并且在10例接受检测的患者中,有9例的血管性血友病因子多聚体高分子量条带减少。13例患者中有7例实现完全缓解(CR),但有6例死亡。肿瘤坏死因子(TNF)、白细胞介素(IL)-1β、IL-6和可溶性IL-2受体在发病时显著升高,在CR时下降。IL-6和可溶性IL-2受体水平升高的患者预后往往较差。这些发现表明,诸如巨噬细胞激活等免疫机制参与了TTP的发病机制,并反映在血浆细胞因子水平上。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验